Postnatal development of bulbospinal serotoninergic system. effects of GMI ganglioside following neonatal 5,7-dihydroxytryptamine treatment
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 13 (2) , 251-259
- https://doi.org/10.1016/0197-0186(88)90062-9
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Neuritogenic and metabolic effects of individual gangliosides and their interaction with nerve growth factor in cultures of neuroblastoma and pheochromocytomaDevelopmental Brain Research, 1986
- Demonstration of an Autoreceptor Modulating the Release of [3H]5-Hydroxytryptamine from a Synaptosomal-Rich Spinal Cord Tissue PreparationJournal of Neurochemistry, 1985
- Gangliosides enhance neurite outgrowth in PC12 cellsDevelopmental Brain Research, 1983
- Developmental Changes in Serotonin and 5-HydroxyindoIeacetic Acid Concentrations and Opiate Receptor Binding in Rat Spinal Cord Following Neonatal 5,7-Dihydroxytryptamine TreatmentDevelopmental Neuroscience, 1982
- Developmental changes in brain indoles, serum tryptophan and other serum neutral amino acids in the ratDevelopmental Brain Research, 1981
- The maturation of cortical serotonin binding sitesDevelopmental Brain Research, 1981
- DEVELOPMENTAL PLASTICITY OF CENTRAL SEROTONIN NEURONS AFTER 5,7‐DIHYDROXYTRYPTAMINE TREATMENT*Annals of the New York Academy of Sciences, 1978
- Long-term effects of 5,7-dihydroxytryptamine administered at birth on the development of brain monoaminesLife Sciences, 1974
- Long-term effects of 5,7-dihydroxytryptamine on brain monoaminesLife Sciences, 1974
- A new procedure for the extraction, purification and fractionation of brain gangliosidesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973